Chief Medical Officer
Adjuvance Technologies, Inc.
Disclosure: Adjuvance Technologies (Employee)
Sean Bennett, M.D., Ph.D., joined the Adjuvance Team as Chief Medical Officer in April 2020. He brings 16 years of clinical development experience, including safety assessment of novel vaccine adjuvants. Dr. Bennett has contributed to the licensure of multiple novel vaccines and anti-infectives and has worked to advance immunotherapeutics, as well. Prior to joining Adjuvance, he led clinical development at PaxVax (subsequently acquired by Emergent BioSolutions), served as Principal at HGB Consulting Limited, and was Senior Medical Director at Aimmune Therapeutics. Dr. Bennett earned his M.D. and Ph.D. (Immunology) from the University of Colorado and trained in pediatrics at Dartmouth.